Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin

Ann Surg Oncol. 2020 Mar;27(3):630-631. doi: 10.1245/s10434-019-08106-z. Epub 2019 Dec 17.

Authors

Sandy Tun¹, Oliver S Eng², Monica Malec³

Affiliations

¹ Department of Medicine, University of Chicago, Chicago, IL, USA.
² Department of Surgery, University of Chicago, Chicago, IL, USA.
³ Department of Medicine, University of Chicago, Chicago, IL, USA. mmalec@medicine.bsd.uchicago.edu.

PMID: 31848812
DOI: 10.1245/s10434-019-08106-z

No abstract available

Publication types

Editorial
Comment

MeSH terms

Appendiceal Neoplasms* / therapy
Cytoreduction Surgical Procedures
Humans
Hyperthermia, Induced*
Mitomycin
Oxaliplatin
Quality of Life

Substances

Oxaliplatin
Mitomycin